“…Until 1968, modern pharmacological investigation on sanghuang was unlocked based on the finding of its remarkable anti-tumor activity by Ikekawa et al ( 1968 ). As a group of ancient, precious, natural, and medicinal fungal resources, sanghuang has been validated by extensive scholars to have fascinating therapeutic functionalities, such as anti-tumor (Huang et al, 2011 ; He et al, 2021a ), antioxidant (Liu et al, 1997 ; Shon et al, 2003 ; Chen et al, 2016 ), anti-bacterial (Lu et al, 2020 ; Ma et al, 2021 ), anti-virus (Mirzadeh et al, 2020 ), anti-angiogenic (Lee Y. S. et al, 2010 ), anti-platelet (Kamruzzaman et al, 2011 ), anti-inflammatory (Kim B. C. et al, 2006 ; Lin et al, 2017 ), immunoregulatory (Meng et al, 2016 ; Azeem et al, 2018 ; Jung and Kang, 2020 ), and hepatoprotective activities (Shan et al, 2019 ; Yang et al, 2020 ), treating diabetes (Hwang et al, 2005 ; Ajith and Janardhanan, 2021 ), hyperlipidemia (Rony et al, 2014 ), and cardiovascular (Lee et al, 2007 ; Su et al, 2017 ) diseases, etc.…”